Related Stories
Pfizer CEO says he used ‘emotional blackmail’ to get employees to achieve impossible goals during COVID-19
Key Excerpts from Article on Website of Fortune
Posted: March 14th, 2026
https://fortune.com/2026/01/29/pfizer-ceo-interview-team-mot...
Pfizer CEO Albert Bourla says he used extreme team-motivating tactics to meet seemingly impossible deadlines during the COVID-19 pandemic. Bourla admitted to using what he called “emotional blackmail” in order to create and deliver vaccines faster. Specifically, his team was tasked with creating a vaccine to combat the new illness from scratch. Once it was created, Pfizer needed to far exceed prior shipping and supply-chain constraints; at one point, it even had to produce its own dry ice because not enough was available externally. Prior to COVID, Pfizer had been producing only 200 million vaccine doses per year. That needed to scale quickly to 3 billion doses. All around the office, Bourla put up signs that read, “Time is life.” On several occasions, employees came to him to say there would need to be a delay of several weeks in meeting deadlines. In response, Bourla asked them to calculate how many people would die during the additional weeks they requested. In April 2020, that would have meant about 1,800 Americans dying per day; any longer delay could mean tens of thousands of lives. He said he feels “a little bit” guilty about putting that much pressure on his workers. But he argues it was necessary, not only to save the “world, the economy, and society, but make them feel like the most important people on earth, those that were able to deliver.” “They will never forget,” Bourla added.
Note: Whistleblowers say that the speed may have come at the cost of data integrity and patient safety. During Pfizer’s pivotal COVID-19 vaccine trials, regional director Brook Jackson reported a long list of concerns: falsified data, unblinded participants, and unresolved safety issues to the FDA and was fired the same day. A short time later, the FDA gave Pfizer's emergency authorization for its vaccine to be used publicly. Despite Jackson's claims, the FDA only visited 9 of the 153 Pfizer trial sites, before giving Pfizer full approval for its vaccine.
Related Stories
Latest News
Key News Articles from Years Past
